Mindray to Acquire a Controlling Stake in Hyssen Electronics
Under the agreement, Mindray will gain access to Hyssen’s urine sediment analysis products, as well as its research and development capabilities. Hyssen’s products complement Mindray’s current in-vitro diagnostic product offerings in urine dry chemistry, hematology and biochemistry. With the new additions, Mindray’s in-vitro diagnostic segment can now provide their customers with better and more complete solutions.
Mindray will utilize its strong platforms in manufacturing, research and development, quality assurance, sales and marketing to support Hyssen’s future development. We aim to work diligently with Hyssen to help strengthen the company’s leading position in urine sediment analysis in China.
We believe that the collaboration between Mindray and Hyssen will bring many synergies to both parties. We expect that our combined efforts will provide better products and services to our customers, broader development opportunities to our employees, and help Hyssen establish a stronger position to compete in the market place.
Located in China-Singapore Suzhou Industrial Park, Hyssen is a developer, manufacturer and marketer of automated urine sediment analyzers. Please refer to www.hyssen.cn for more information.
July 08, 2011
Open WeChat and Scan the QR code .Get the Webpage and Share on Moments.
Mindray becomes the first China medical device manufacturer that received MDR certificate2019-11-22
Mindray Showcases Comprehensive Innovations at MEDICA 20192019-11-20
Mindray launches the new BeneHeart C Series AED to enhance resuscitation confidence2019-09-12
Mindray Showcases Latest IVD Innovations at EuroMedlab 20192019-06-28
Mindray at CMEF 2019: A Journey of Global Healthcare2019-05-20